Rising rates of colon cancer in adults younger than 50 continue to puzzle medical experts. But recent research from Cleveland Clinic found changes in the tumor-associated bacteria of patients under 50 with a colon cancer diagnosis.

The National Comprehensive Cancer Network, a non-profit comprised of 33 leading cancer centers across the U.S., has published the first set of guidelines for oncologists about treating solid tumors in children.

New findings from researchers at Cleveland Clinic have revealed that bacteria in tumors from patients with young-onset colorectal cancer are compositionally distinct, which could help inform targeted approaches to screening and treatments. 

Most cancer centers and hospitals with strong cancer programs were rated in the "A" range by Moody, a global provider of credit ratings and risk assessment.

The first patient to receive purified CAR-T cells is home and doing well, Charleston, S.C.-based MUSC Hollings Cancer Center said.

Of all cancer cases in men in 2024, 48% are predicted to be prostate, lung and colon and rectum and 51% of all new cases in women are expected to be from breast, lung and colon and rectum cancers, researchers from the American Cancer Society found.

A "legendary" Houston oncologist has developed a novel cancer treatment that boasts a complete remission rate among patients of 50%, ABC7 reported Feb. 3.

Here are six cancer vaccines showing promise or in development since May 2023: 

Early trials of a vaccine that targets a specific gene found in tumors, known as KRAS, has proven to be effective in 84% of patients who had pancreatic or colorectal cancers recur after their initial treatment, according to researchers at Memorial Sloan Kettering Cancer Center in New York City who co-led the study.

Little Rock-based University of Arkansas for Medical Sciences reached its $30 million fundraising goal and is closer to becoming a national cancer institute.

New estimates suggest that global cancer cases will spike around 77% by 2050, according to a Feb. 1 United Nations report. 

The Rutgers Cancer Institute of New Jersey has promoted two leadership positions to better situate it for support of the new Jack and Sheryl Morris Cancer Center in New Brunswick, N.J., set to open in early 2025.

Houston-based University of Texas MD Anderson Cancer Center is the first International Atomic Energy Agency Collaborating Centre in the United States focused on healthcare.

Alexandra Miller, MD, PhD, a neurologist and neuro-oncologist who specializes in brain tumors, was named chief of the neuro-oncology program and co-director of the Brain and Spine Tumor Center at New York City-based NYU Langone's Perlmutter Cancer Center.

Calling the lowest-risk prostate cancers something else may encourage some patients to follow physicians' treatment recommendations of active surveillance and avoid pursuing more aggressive options, according to a growing number of physicians advocating for a change in nomenclature, The Wall Street Journal reported Jan. 24.

Researchers have identified 921 chemicals thought to increase the risk of breast cancer and say none should be considered "low hazard" until further investigation is done.

Los Angeles-based Cedars-Sinai is using artificial intelligence to improve prediction of and treatment for pancreatic cancer, according to a Jan. 22 news release. 

In an interactive session hosted by GRAIL at Becker's 11th Annual CEO + CFO Roundtable, Roni Christopher, DHSc, senior director of care delivery at GRAIL, and Adam Whitten, vice president of operations at Mercy (St. Louis), discussed how multi-cancer early detection testing can support health systems and patient outcomes.

Biotech company Orbis Health Solutions was approved to begin a phase 3 clinical trial of its melanoma vaccine, ABC News reported Jan. 20.

This is the first year since the COVID-19 pandemic began that hospitals must independently decide if and how to implement masking, and cancer centers across the country are taking different approaches.